SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-10-031820
Filing Date
2010-06-01
Accepted
2010-06-01 17:06:07
Documents
16
Effectiveness Date
2010-06-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A a10-9595_20defa14a.htm DEFA14A 70712
2 GRAPHIC g959520bei001.gif GRAPHIC 170616
3 GRAPHIC g959520bei002.gif GRAPHIC 73537
4 GRAPHIC g959520bei003.gif GRAPHIC 57326
5 GRAPHIC g959520bei004.gif GRAPHIC 81074
6 GRAPHIC g959520bei005.gif GRAPHIC 96317
7 GRAPHIC g959520bei006.gif GRAPHIC 69003
8 GRAPHIC g959520bei007.gif GRAPHIC 94576
9 GRAPHIC g959520bei008.gif GRAPHIC 89918
10 GRAPHIC g959520bei009.gif GRAPHIC 187815
11 GRAPHIC g959520bei010.gif GRAPHIC 100697
12 GRAPHIC g959520bei011.gif GRAPHIC 73162
13 GRAPHIC g959520bei012.gif GRAPHIC 67156
14 GRAPHIC g959520bei013.gif GRAPHIC 64510
15 GRAPHIC g959520bei014.gif GRAPHIC 57449
16 GRAPHIC g959520bii001.gif GRAPHIC 52071
  Complete submission text file 0001104659-10-031820.txt   1913996
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-14680 | Film No.: 10870431
SIC: 2836 Biological Products, (No Diagnostic Substances)